1.
Iron Acquisition by Bacterial Pathogens: Beyond Tris-Catecholate Complexes.
Zhang, Y, Sen, S, Giedroc, DP
Chembiochem : a European journal of chemical biology. 2020;(14):1955-1967
-
-
Free full text
-
Abstract
Sequestration of the essential nutrient iron from bacterial invaders that colonize the vertebrate host is a central feature of nutritional immunity and the "fight over transition metals" at the host-pathogen interface. The iron quota for many bacterial pathogens is large, as iron enzymes often make up a significant share of the metalloproteome. Iron enzymes play critical roles in respiration, energy metabolism, and other cellular processes by catalyzing a wide range of oxidation-reduction, electron transfer, and oxygen activation reactions. In this Concept article, we discuss recent insights into the diverse ways that bacterial pathogens acquire this essential nutrient, beyond the well-characterized tris-catecholate FeIII complexes, in competition and cooperation with significant host efforts to cripple these processes. We also discuss pathogen strategies to adapt their metabolism to less-than-optimal iron concentrations, and briefly speculate on what might be an integrated adaptive response to the concurrent limitation of both iron and zinc in the infected host.
2.
Coagulation behavior and floc characteristics of a novel composite poly-ferric aluminum chloride-polydimethyl diallylammonium chloride coagulant with different OH/(Fe3+ + Al3+) molar ratios.
Sun, C, Qiu, J, Zhang, Z, Marhaba, TF, Zhang, Y
Water science and technology : a journal of the International Association on Water Pollution Research. 2016;(7):1636-1643
Abstract
In this paper, flocculating performance and mechanisms of a new composite coagulant, poly-ferric aluminum chloride-polydimethyl diallylammonium chloride (PFAC-PD) with different OH-/(Fe3+ + Al3+) molar ratios, were investigated for humic acid (HA)-kaolin synthetic wastewater treatment. The impact of OH-/(Fe3+ + Al3+) molar ratios on the removal efficiencies of turbidity and dissolved organic carbon, specific UV absorbance, coagulation mechanisms and dynamics was explored during the coagulation process using composite coagulants. The coagulation experimental results revealed that the composite coagulants with lower OH-/(Fe3+ + Al3+) molar ratio exhibited better coagulation efficiency. When OH-/(Fe3+ + Al3+) molar ratio of the composite coagulant was 1.5, adsorption-bridging played a dominant role in coagulating HA-kaolin synthetic wastewater. The floc growth rate and floc size, increased with increasing OH-/(Fe3+ + Al3+) molar ratio and the highest peak height of the size distribution was obtained by PFAC-PD with OH-/(Fe3+ + Al3+) = 1.5. Also, the composite coagulants with higher OH-/(Fe3+ + Al3+) molar ratio formed more compact flocs, as reflected by the higher fractal dimension value. The flocs coagulated by PFAC-PD with basicity value of 1.0 gave strong strength and good recoverability.
3.
A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles.
Zhang, Y, Yang, M, Park, JH, Singelyn, J, Ma, H, Sailor, MJ, Ruoslahti, E, Ozkan, M, Ozkan, C
Small (Weinheim an der Bergstrasse, Germany). 2009;(17):1990-6
-
-
Free full text
-
Abstract
Surface-charge measurements of mammalian cells in terms of Zeta potential are demonstrated as a useful biological characteristic in identifying cellular interactions with specific nanomaterials. A theoretical model of the changes in Zeta potential of cells after incubation with nanoparticles is established to predict the possible patterns of Zeta-potential change to reveal the binding and internalization effects. The experimental results show a distinct pattern of Zeta-potential change that allows the discrimination of human normal breast epithelial cells (MCF-10A) from human cancer breast epithelial cells (MCF-7) when the cells are incubated with dextran coated iron oxide nanoparticles that contain tumor-homing F3 peptides, where the tumor-homing F3 peptide specifically bound to nucleolin receptors that are overexpressed in cancer breast cells.